A Study to Compare Plasma Levels of Levodopa, Carbidopa and Entacapone After TRIGEL or Duodopa Infusion in PD Patients
Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
This study evaluates the continuous addition of entacapone to infused levodopa and carbidopa
on the pharmacokinetic (PK) profile in patients with advanced Parkinson's disease (PD). All
patients will receive both study drugs, i.e. TRIGEL (levodopa, carbidopa, and entacapone) and
Duodopa (levodopa and carbidopa), in randomized order.
Phase:
Phase 1
Details
Lead Sponsor:
LobSor Pharmaceuticals AB
Collaborator:
TFS Trial Form Support
Treatments:
Carbidopa Carbidopa, levodopa drug combination Entacapone Levodopa